SC 13G/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

SCHEDULE 13G/A

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 21)*

 

 

CorVel Corporation

(Name of Issuer)

Common Stock, $0.0001 Par Value Per Share

(Title of Class of Securities)

221006109

(CUSIP Number)

December 31, 2017

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

(Page 1 of 5 Pages)


CUSIP NO. 221006109    13G/A    Page 2 of 5 Pages

 

  1.       

  NAMES OF REPORTING PERSONS

 

  V. Gordon Clemons

  2.      

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)  ☐        (b)  ☐

 

  3.      

  SEC USE ONLY

 

  4.      

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  United States of America

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH:

   5.      

  SOLE VOTING POWER

 

  1,990,546

   6.     

  SHARED VOTING POWER

 

  0

   7.     

  SOLE DISPOSITIVE POWER

 

  1,990,546

   8.     

  SHARED DISPOSITIVE POWER

 

  0

  9.      

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  1,990,546

10.      

  CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

 

  ☐

11.      

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

  10.5%

12.      

  TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

  IN


CUSIP NO. 221006109    13G/A    Page 3 of 5 Pages

 

Item 1(a). Name of Issuer:

CorVel Corporation (the “Issuer”)

 

Item 1(b). Address of Issuer’s Principal Executive Offices:

2010 Main Street, Suite 600

Irvine, CA 92614

 

Item 2(a). Name of Person Filing:

V. Gordon Clemons (“Mr. Clemons”)

 

Item 2(b). Address of Principal Business Office or, if None, Residence:

c/o CorVel Corporation

2010 Main Street, Suite 600, Irvine, CA 92614

 

Item 2(c). Citizenship

United States of America

 

Item 2(d). Title of Class of Securities:

Common Stock, $0.0001 Par Value Per Share

 

Item 2(e). CUSIP Number:

221006109

 

Item 3. If This Statement is Filed Pursuant to Sections 240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:

(a) Broker or dealer registered under section 15 of the Act;

(b) Bank as defined in section 3(a)(6) of the Act;

(c) Insurance company as defined in section 3(a)(19) of the Act;

(d) Investment company registered under section 8 of the Investment Company Act of 1940;

(e) An investment adviser in accordance with Section 240.13d-1(b)(1)(ii)(E);

(f) An employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F);

(g) A parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G);

(h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;

(i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;

(j) A non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J);

(k) Group, in accordance with Section 240.13d-1(b)(1)(ii)(J).

If filing as a non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

Not Applicable

 

Item 4. Ownership.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

(a)    Amount Beneficially Owned: 1,990,546

(b)    Percent of Class: 10.5%


 

CUSIP NO. 221006109    13G/A    Page 4 of 5 Pages

(c)    Number of shares as to which the person has:

 

(i)

 

  

Sole power to vote or to direct the vote:

   1,990,546

(ii)

 

  

Shared power to vote or to direct the vote:

                 0

(iii)

 

  

Sole power to dispose or to direct the disposition of:

   1,990,546

(iv)

  

Shared power to dispose or to direct the disposition of:

                 0

As of December 31, 2017, Mr. Clemons beneficially owns 1,990,546 shares of Common Stock of the Issuer, which includes 20,000 options which are exercisable within 60 days of December 31, 2017.

Mr. Clemons’ beneficial ownership, including all shares owned directly and pursuant to options which are exercisable within 60 days of December 31, 2017, represents 10.5% in the aggregate of the Issuer’s outstanding Common Stock.

 

Item 5. Ownership of 5 Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following.  

Not Applicable

 

Item 6. Ownership of More than 5 Percent on Behalf of Another Person.

Not Applicable

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable

 

Item 8. Identification and Classification of Members of the Group.

Not Applicable

 

Item 9. Notice of Dissolution of Group.

Not Applicable

 

Item 10. Certifications.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Section 240.14a-11.


CUSIP NO. 221006109    13G/A    Page 5 of 5 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 16, 2018      

/s/ V. GORDON CLEMONS

      Name: V. Gordon Clemons

The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, Provided, however, That a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d–7 for other parties for whom copies are to be sent.

Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).